Annexon, Inc. Share Price
ANNXAnnexon, Inc. Stock Performance
Open $6.21 | Prev. Close $6.14 | Circuit Range N/A |
Day Range $5.75 - $6.21 | Year Range $1.29 - $7.16 | Volume 58,061 |
Average Traded $5.97 |
Annexon, Inc. Share Price Chart
About Annexon, Inc.
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. The company's lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase 2a clinical trial for the treatment of amyotrophic lateral sclerosis. The company is also developing ANX007, an antigen-binding fragment (Fab) that is in Phase 3 program for the treatment of patients with geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, which is in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab that is in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California.
Annexon, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
08-Apr-26 | $6.29 | $6.05 | +0.83% |
07-Apr-26 | $5.68 | $6.00 | +3.54% |
06-Apr-26 | $5.51 | $5.79 | +5.36% |
02-Apr-26 | $5.15 | $5.50 | +2.71% |
01-Apr-26 | $5.72 | $5.36 | -3.51% |
31-Mar-26 | $5.68 | $5.55 | +11.90% |
30-Mar-26 | $5.08 | $4.96 | -0.80% |
FAQs on Annexon, Inc. Share Price
Can I buy Annexon, Inc. shares in India?
What is the share price of Annexon, Inc.?
What is the 5 year returns of Annexon, Inc.?
What are the high & low stock price of Annexon, Inc. today?
What is the 52-week high and low of Annexon, Inc. stock?